Events

Participate in our Events

Members of APCaRI are involved in a wide range of translational, clinical and discovery research events such as scientific conferences and meetings. These meetings help keep us at the forefront of scientific discovery and application. Our scientists and trainees present posters and give talks helping stimulate interest in the overall program by national and international collaborations

We are also invested in the local and provincial community, reaching out to Albertans through many events tied to fundraising and prostate cancer awareness. We work alongside organizations like the Alberta Cancer foundation, Prostate Cancer Canada, MotorCycle Ride for Dad and Movember to help stimulate fundraising as well as provide the donors with a direct link and people to answer questions about where their donated dollars actually go.

The staff at the Alberta Cancer Foundation have harnessed our group for many events since we have arrived in Alberta.

 

2018 APCaRI Fall Symposium

Our fall APCaRI 2018 symposium wrapped up on Saturday afternoon after two days of excellent seminars, great food, lots of coffee, bowling, hikes around Banff, get-togethers at the local pub, and beautiful fall weather with minimal snowfall!

The APCaRI meeting was attended by people from across Canada and the USA representing the Alberta Cancer Foundation, Bird Dogs for Prostate Cancer Research, Cross Cancer Institute, DynaLIFE Medical Labs, Edmonton Health City, Entos Pharmaceuticals, Institute of Health Economics, Nanostics Inc, Northern Alberta Urology Centre, Oisin Biotechnologies, PandiaDX, PROSTAID Calgary, Prostate Cancer Centre, Prostate Cancer Support Group, University of Alberta, University of Calgary, Western University, and the Yukon Hospital Corporation.
The invited speakers gave excellent keynote talks that kick-started interesting conversations during the meeting.

Dr. Alison Allan from Western University gave the Friday keynote seminar on developing circulating tumour cells as liquid biospies for early detection of cancers.

Dr. Melina Cimler, CEO of PandiaDX, and Saturday’s keynote speaker, outlined the potentially complex regulatory pathways that molecular diagnostic companies need to navigate when pursuing regulation in the USA.


Thank you to Rume Djebah for organizing the 2018 APCaRI Fall Symposium!

- Perrin Beatty